Research shows that even a modest reduction in body weight (about 510%) can significantly decrease liver fat, reduce inflammation, and improve liver enzyme levels
AEs were mostly gastrointestinal in nature, consistent with other tirzepatide trials ( Study limitations included differences in body weight and glycemic control (as determined by HbA1c and insulin sensitivity) with tirzepatide versus placebo
Unlike gradual vision loss where patients can adapt over time, NAIONs acute onset leaves victims unprepared for a world designed for sighted individuals, necessitating immediate accommodations, vocational rehabilitation, and extensive support services
Serious side effects like pancreatitis are rare but should be recognized
Patients may feel less hungry, eat smaller portions, skip meals unintentionally, or become more sensitive to foods they previously tolerated